Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups.

Mahaffey, Kenneth W; Jardine, Meg J; Bompoint, Severine; Cannon, Christopher P; Neal, Bruce; Heerspink, Hiddo J L; Charytan, David M; Edwards, Robert; Agarwal, Rajiv; Bakris, George; Bull, Scott; Capuano, George; de Zeeuw, Dick; Greene, Tom; Levin, Adeera; Pollock, Carol; Sun, Tao; Wheeler, David C; Yavin, Yshai; Zhang, Hong; Zinman, Bernard; Rosenthal, Norman; Brenner, Barry M; Perkovic, Vlado.
Circulation; 140(9): 739-750, 2019 Aug 27.
Artigo em Inglês | MEDLINE | ID: mdl-31291786

Não foram localizados documentos relacionados